Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Vet Rec ; 165(7): 200-2, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19684345

ABSTRACT

Eleven miniature dachshunds with a herniated intervertebral disc were examined by CT, first before and then after contrast enhancement of the subarachnoid space. The images were classified into three grades by three veterinarians. In four cases, lesions observed on the scans obtained after contrast enhancement had not been observed on the preliminary scans and in one case a lesion observed on the preliminary scan was not observed on the scan obtained after contrast enhancement. Hemilaminectomies were performed on the basis of the enhanced CT results, and a clinical improvement was observed in each of the dogs. Calcification was detected in all the samples of herniated intervertebral disc material.


Subject(s)
Dog Diseases/diagnosis , Intervertebral Disc Displacement/veterinary , Intervertebral Disc/pathology , Myelography/veterinary , Tomography, X-Ray Computed/veterinary , Animals , Calcinosis/diagnosis , Calcinosis/pathology , Calcinosis/surgery , Calcinosis/veterinary , Contrast Media , Dog Diseases/pathology , Dog Diseases/surgery , Dogs , Intervertebral Disc/surgery , Intervertebral Disc Displacement/diagnosis , Intervertebral Disc Displacement/pathology , Intervertebral Disc Displacement/surgery , Laminectomy/veterinary , Severity of Illness Index , Subarachnoid Space , Tomography, X-Ray Computed/methods
2.
Microbiol Immunol ; 37(7): 583-90, 1993.
Article in English | MEDLINE | ID: mdl-8231971

ABSTRACT

The lymphokine production by pregnant mice infected with a lethal dose of Toxoplasma gondii was evaluated in comparison with that by virgin mice infected with a sublethal dose of this protozoan parasite. Splenocytes taken from mice before and on the day after infection produced considerable amounts of IL-2 in response to concanavalin A (Con A) stimulation, but the titers rapidly declined in both pregnant and virgin mice as infection progressed. A trace amount or undetectable level of IL-2 was produced by splenocytes from acutely infected mice when stimulated with Toxoplasma lysate antigen (TLA). In contrast to the kinetics of IL-2 production, the levels of IFN-gamma produced by splenocytes cultured with Con A or TLA increased steadily in the later stage of infection in both pregnant and virgin mice. Thus, the response to Con A or TLA of splenocytes to produce IL-2 and IFN-gamma differed strikingly in acute toxoplasmosis in mice. The administration of rHuIL-2 resulted in a significant decrease in the mortality of pregnant mice infected with a lethal dose of Toxoplasma. The combination of rHuIL-2 and rMuIFN-gamma increased the survival rate slightly but not significantly compared with pregnant mice receiving either rHuIL-2 or rMuIFN-gamma. Moreover, exogenously administered rHuIL-2 enhanced the production of both IFN-alpha and IFN-gamma in the bloodstreams of pregnant mice, in accordance with the decreased mortality. These results indicate that IL-2 may play a significant role in modulating the host defense against Toxoplasma infection in pregnant mice.


Subject(s)
Interleukin-2/therapeutic use , Pregnancy Complications, Parasitic/drug therapy , Pregnancy, Animal , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/drug therapy , Acute Disease , Animals , Female , Immunity, Innate , Interferon-gamma/biosynthesis , Interferon-gamma/therapeutic use , Interleukin-2/biosynthesis , Mice , Mice, Inbred ICR , Pregnancy , Recombinant Proteins/therapeutic use , Spleen/metabolism , Toxoplasmosis, Animal/mortality
3.
Microbiol Immunol ; 36(1): 81-91, 1992.
Article in English | MEDLINE | ID: mdl-1584075

ABSTRACT

To explore a possible mechanism of pregnancy-associated suppression of T cell-mediated immunity to Toxoplasma gondii, acquired resistance and gamma interferone (IFN-gamma) production in pregnant mice were compared with those in virgin mice after infection with the S-273 strain of this protozoan parasite. The 50% lethal dose of this strain was less than 200 tachyzoites for pregnant mice and 2,800 organisms for virgin controls. Toxoplasma-induced production of both IFN-alpha and IFN-gamma in the bloodstream of pregnant mice was significantly depressed as compared with that in virgin controls. The administration of recombinant murine IFN-gamma (rMuIFN-gamma) resulted in a significant decrease of mortality and parasitic growth in the organs of pregnant mice infected with a lethal dose of S-273 strain tachyzoites. Thus, the impairment of T cell-mediated immune responses was evident in pregnant mice from the impaired IFN-gamma-generating capacity and poor survival rate after primary infection with Toxoplasma. When mice with chronic Toxoplasma infection were injected with specific antigen, the resultant production of IFN-gamma was also significantly suppressed during pregnancy. However, there was no direct correlation between the serum levels of IFN-gamma and susceptibility to reinfection, since the mortality rate of chronically infected pregnant mice after the challenge with the high virulent RH strain was not significantly higher than that of virgin controls.


Subject(s)
Interferon-gamma/deficiency , Pregnancy, Animal/immunology , Toxoplasmosis, Animal/immunology , Animals , Disease Susceptibility , Female , Immune Tolerance , Interferon-gamma/biosynthesis , Mice , Mice, Inbred ICR , Pregnancy , Toxoplasmosis, Animal/mortality
4.
J Biochem ; 79(1): 203-15, 1976 Jan.
Article in English | MEDLINE | ID: mdl-939757

ABSTRACT

Pyruvate kinase [EC 2.7.1.40] in various tissues of rats was separable into seven kinds of pI-isozymes by isoelectric separation with Ampholine carrier ampholytes; pI 5.4-isozyme, pI 5.6-isozyme, pI 6.2-isozyme (2 kinds), pI 6.6-isozyme, pI 7.4-isozyme, and pI 7.8-isozyme. Some of these pI-isozymes contained bound fructose 1,6-diphosphate (FDP). The bound FDP was completely dissociated when the pI-isozymes were salted out with ammonium sulfate. In the FDP-free form, pyruvate kinase was classified into three types, liver-type (type L) of pI 6.2, muscle-type (type M) of pI 7.4, and spleen-type (type M2) of pI 7.8. The liver-type isoenzyme had two kinds of FDP-binding sites; the pI 5.6-isozyme and pI 5.4-isozyme were obtained when one and two kinds of sites were bound with FDP, respectively. The association and dissociation of FDP at both sites were reversible in the presence and absence of 0.15 M KC1 (high ionic strength). The muscle-type isoenzyme had no FDP-binding site. The spleen-type isoenzyme had two kinds of FDP-binding sites, like the liver-type isoenzyme. When the ionic strength of solutions containing the enzyme and FDP was sufficiently low, one and two kinds of the sites could bind with FDP, converting the enzyme into pI 6.6-isozyme and pI 6.2-isozyme, respectively. FDP bound with one kind of site (the 2nd site) was easily dissociable, but FDP bound with the other kind of site (the 1st site) was not. Provided that the 1st site carried bound FDP, the 2nd site was associable at high ionic strength. The liver-type isoenzyme free of FDP and the spleen-type isoenzyme bound with FDP at both sites had similar pI values of 6.2 and were not separable by isoelectric separation. Some properties of these pI-isozymes were compared. When Rhodamine sarcoma was transplanted in rats, the content of spleen-type isoenzyme in the livers increased. When rats were injected with chromatin prepared from either Rhodamine sarcoma or spleen, the content of spleen-type isoenzyme in the livers again increased. This was not observed on the injection of chromatin prepared from liver, indicating that the factor capable of controlling the gene expression was present in chromatins of sarcoma and spleen but barely or not at all in chromatin of liver.


Subject(s)
Chromatin/pharmacology , Liver/enzymology , Pyruvate Kinase/metabolism , Sarcoma, Experimental/enzymology , Spleen/enzymology , Animals , Binding Sites , Fructosephosphates/metabolism , Isoenzymes/metabolism , Kinetics , Male , Molecular Weight , Muscles/enzymology , Phosphoenolpyruvate/pharmacology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL